{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T21:06:13Z","timestamp":1773090373158,"version":"3.50.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2005,4,21]],"date-time":"2005-04-21T00:00:00Z","timestamp":1114041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2005,4,21]],"date-time":"2005-04-21T00:00:00Z","timestamp":1114041600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Hypertens"],"published-print":{"date-parts":[[2005,8,1]]},"DOI":"10.1038\/sj.jhh.1001869","type":"journal-article","created":{"date-parts":[[2005,6,9]],"date-time":"2005-06-09T09:16:56Z","timestamp":1118308616000},"page":"643-652","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["The impact of oral phenylpropanolamine on blood pressure: a meta-analysis and review of the literature"],"prefix":"10.1038","volume":"19","author":[{"given":"S M","family":"Salerno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J L","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E P","family":"Berbano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,4,21]]},"reference":[{"key":"BF1001869_CR1","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1001\/jama.1984.03350140044023","volume":"252","author":"P Pentel","year":"1984","unstructured":"Pentel P . Toxicity of over-the-counter stimulants. JAMA 1984; 252: 1898\u20131903.","journal-title":"JAMA"},{"key":"BF1001869_CR2","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/0002-9343(90)90299-S","volume":"89","author":"CR Lake","year":"1990","unstructured":"Lake CR, Gallant S, Masson E, Miller P . Adverse drug effects attributed to phenylpropanolamine: a review of 142 case reports. Am J Med 1990; 89: 195\u2013208.","journal-title":"Am J Med"},{"key":"BF1001869_CR3","first-page":"396","volume":"56","author":"K Radack","year":"1986","unstructured":"Radack K, Deck CC . Are oral decongestants safe in hypertension? An evaluation of the evidence and a framework for assessing clinical trials. Ann Allergy 1986; 56: 396\u2013401.","journal-title":"Ann Allergy"},{"issue":"Suppl","key":"BF1001869_CR4","doi-asserted-by":"publisher","first-page":"206S","DOI":"10.1093\/ajcn\/55.1.206s","volume":"55","author":"JP Morgan","year":"1992","unstructured":"Morgan JP, Funderburk FR . Phenylpropanolamine and blood pressure: a review of prospective studies. Am J Clin Nutr 1992; 55 (Suppl): 206S\u2013210S.","journal-title":"Am J Clin Nutr"},{"key":"BF1001869_CR5","unstructured":"U.S. Food and Drug Administration Center for Drug Evaluation and Research Phenylpropanolamine (PPA) Information Page. Available at: http:\/\/www.fda.gov\/cder\/drug\/infopage\/ppa; Accessed December 30, 2003."},{"key":"BF1001869_CR6","unstructured":"(CSM) CoSoM. Important safety message: phenylpropanolamine and haemorrhagic stroke \u2014 update. Available at: http:\/\/medicines.mhra.gov.uk\/ourwork\/monitorsafequalmed\/safetymessages\/ppaupdate.htm; Accessed December 30, 2003."},{"key":"BF1001869_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","volume":"17","author":"AR Jadad","year":"1996","unstructured":"Jadad AR et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17: 1\u201312.","journal-title":"Control Clin Trials"},{"key":"BF1001869_CR8","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C . Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629\u2013634.","journal-title":"BMJ"},{"key":"BF1001869_CR9","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1002\/sim.4780070807","volume":"7","author":"RF Galbraith","year":"1988","unstructured":"Galbraith RF . A note on graphical presentation of estimated odds ratios from several clinical trials. Stat Med 1988; 7: 889\u2013894.","journal-title":"Stat Med"},{"key":"BF1001869_CR10","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N . Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177\u2013188.","journal-title":"Control Clin Trials"},{"key":"BF1001869_CR11","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/j.0006-341X.2000.00455.x","volume":"56","author":"S Duval","year":"2000","unstructured":"Duval S, Tweedie R . Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 2000; 56: 455\u2013463.","journal-title":"Biometrics"},{"key":"BF1001869_CR12","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/sim.4780140406","volume":"14","author":"CS Berkey","year":"1995","unstructured":"Berkey CS, Hoaglin DC, Mosteller F, Colditz GA . A random-effects regression model for meta-analysis. Stat Med 1995; 14: 395\u2013411.","journal-title":"Stat Med"},{"key":"BF1001869_CR13","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1093\/ajcn\/57.2.120","volume":"57","author":"S Alger","year":"1993","unstructured":"Alger S et al. Effect of phenylpropanolamine on energy expenditure and weight loss in overweight women. Am J Clin Nutr 1993; 57: 120\u2013126.","journal-title":"Am J Clin Nutr"},{"issue":"22","key":"BF1001869_CR14","doi-asserted-by":"publisher","first-page":"3267","DOI":"10.1001\/jama.1989.03420220081031","volume":"261","author":"GL Blackburn","year":"1989","unstructured":"Blackburn GL et al. Determinants of the pressor effect of phenylpropanolamine in healthy subjects. JAMA 1989; 261 (22): 3267\u20133272.","journal-title":"JAMA"},{"key":"BF1001869_CR15","first-page":"74","volume":"46","author":"MH Bradley","year":"1989","unstructured":"Bradley MH, Raines J . The effects of phenylpropanolamine hydrochloride in overweight patients with controlled stable hypertension. Curr Therapeutic Res 1989; 46: 74\u201384.","journal-title":"Curr Therapeutic Res"},{"key":"BF1001869_CR16","first-page":"205","volume":"28","author":"R Dowse","year":"1990","unstructured":"Dowse R, Scherzinger SS, Kanfer I . Serum concentrations of phenylpropanolamine and associated effects on blood pressure in normotensive subjects: a pilot-study. Int J Clin Pharmacol Ther Toxicol 1990; 28: 205\u2013210.","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"key":"BF1001869_CR17","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/clpt.1986.153","volume":"40","author":"RP Goodman","year":"1986","unstructured":"Goodman RP et al. The effect of phenylpropanolamine on ambulatory blood pressure. Clin Pharmacol Ther 1986; 40: 144\u2013147.","journal-title":"Clin Pharmacol Ther"},{"key":"BF1001869_CR18","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1080\/00016489950180298","volume":"119","author":"P Graf","year":"1999","unstructured":"Graf P, Toll K, Palm J, Hallen H . Effects of sustained-release oral phenylpropanolamine on the nasal mucosa of healthy subjects. Acta Otolaryngol 1999; 119: 837\u2013842.","journal-title":"Acta Otolaryngol"},{"key":"BF1001869_CR19","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1177\/00912700122010302","volume":"41","author":"PE Hendershot","year":"2001","unstructured":"Hendershot PE et al. Linezolid: pharmacokinetic and pharmacodynamic evaluation of coadministration with pseudoephedrine HCl, phenylpropanolamine HCl, and dextromethorpan HBr. J Clin Pharmacol 2001; 41: 563\u2013572.","journal-title":"J Clin Pharmacol"},{"key":"BF1001869_CR20","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/S0140-6736(80)90490-0","volume":"1","author":"JD Horowitz","year":"1980","unstructured":"Horowitz JD et al. Hypertensive responses induced by phenylpropanolamine in anorectic and decongestant preparations. Lancet 1980; 1: 60\u201361.","journal-title":"Lancet"},{"key":"BF1001869_CR21","doi-asserted-by":"publisher","first-page":"175","DOI":"10.5694\/j.1326-5377.1979.tb128964.x","volume":"1","author":"JD Horowitz","year":"1979","unstructured":"Horowitz JD et al. Hypertension and postural hypotension induced by phenylpropanolamine (Trimolets). Med J Aust 1979; 1: 175\u2013176.","journal-title":"Med J Aust"},{"key":"BF1001869_CR22","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.7326\/0003-4819-111-12-1043","volume":"111","author":"K Kroenke","year":"1989","unstructured":"Kroenke K et al. The safety of phenylpropanolamine in patients with stable hypertension. Ann Intern Med 1989; 111: 1043\u20131044.","journal-title":"Ann Intern Med"},{"key":"BF1001869_CR23","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/0002-9343(88)90583-9","volume":"85","author":"CR Lake","year":"1988","unstructured":"Lake CR et al. A double dose of phenylpropanolamine causes transient hypertension. Am J Med 1988; 85: 339\u2013343.","journal-title":"Am J Med"},{"issue":"4","key":"BF1001869_CR24","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/0002-9343(89)90341-0","volume":"86","author":"CR Lake","year":"1989","unstructured":"Lake CR et al. Transient hypertension after two phenylpropanolamine diet aids and the effects of caffeine: a placebo-controlled follow-up study. Am J Med 1989; 86 (4): 427\u2013432.","journal-title":"Am J Med"},{"key":"BF1001869_CR25","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1002\/j.1552-4604.1991.tb03748.x","volume":"31","author":"CR Lake","year":"1991","unstructured":"Lake CR et al. Dose-dependent response to phenylpropanolamine: inhibition of orthostasis. J Clin Pharmacol 1991; 31: 624\u2013635.","journal-title":"J Clin Pharmacol"},{"key":"BF1001869_CR26","first-page":"236","volume":"75","author":"T Lehtonen","year":"1986","unstructured":"Lehtonen T et al. The effect of phenylpropanolamine on female stress urinary incontinence. Ann Chir Gynaecol 1986; 75: 236\u2013241.","journal-title":"Ann Chir Gynaecol"},{"key":"BF1001869_CR27","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1002\/j.1552-4604.1987.tb03089.x","volume":"27","author":"I Liebson","year":"1987","unstructured":"Liebson I, Bigelow G, Griffiths RR, Funderburk FR . Phenylpropanolamine: effects on subjective and cardiovascular variables at recommended over-the-counter dose levels. J Clin Pharmacol 1987; 27: 685\u2013693.","journal-title":"J Clin Pharmacol"},{"issue":"3","key":"BF1001869_CR28","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1177\/106002809102500302","volume":"25","author":"JM McKenney","year":"1991","unstructured":"McKenney JM, Wright Jr JT, Katz GM, Goodman RP . The effect of phenylpropanolamine on 24-hour blood pressure in normotensive subjects administered indomethacin. DICP 1991; 25 (3): 234\u2013239.","journal-title":"DICP"},{"key":"BF1001869_CR29","first-page":"47","volume":"16","author":"C Mitchell","year":"1969","unstructured":"Mitchell C . Possible cardiovascular effect of phenylpropanolamine and belladonna alkaloids. Curr Therap Res Clin Exp 1969; 16: 47\u201352.","journal-title":"Curr Therap Res Clin Exp"},{"key":"BF1001869_CR30","first-page":"296","volume":"22","author":"R Noble","year":"1988","unstructured":"Noble R . A controlled clinical trial of the cardiovascular and psychological effects of phenylpropanolamine and caffeine. Drug Intell Clin Pharm 1988; 22: 296\u2013299.","journal-title":"Drug Intell Clin Pharm"},{"key":"BF1001869_CR31","first-page":"606","volume":"36","author":"E Nuotto","year":"1984","unstructured":"Nuotto E, Seppala T . Phenylpropanolamine counteracts diazepam effects in psychophysiological tests. Curr Therap Res Clin Exp 1984; 36: 606\u2013616.","journal-title":"Curr Therap Res Clin Exp"},{"key":"BF1001869_CR32","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/j.1875-9114.1990.tb02554.x","volume":"10","author":"MB O\u2019Connell","year":"1990","unstructured":"O\u2019Connell MB, Gross CR . The effect of single-dose phenylpropanolamine on blood pressure in patients with hypertension controlled by beta blockers. Pharmacotherapy 1990; 10: 85\u201391.","journal-title":"Pharmacotherapy"},{"key":"BF1001869_CR33","first-page":"115","volume":"9","author":"PR Pentel","year":"1985","unstructured":"Pentel PR, Aaron C, Paya C . Therapeutic doses of phenylpropanolamine increase supine systolic blood pressure. Int J Obes 1985; 9: 115\u2013119.","journal-title":"Int J Obes"},{"key":"BF1001869_CR34","first-page":"199","volume":"12","author":"PR Pentel","year":"1988","unstructured":"Pentel PR, Eisen T . Effects of phenylpropanolamine and isometric exercise on blood pressure. Int J Obes 1988; 12: 199\u2013204.","journal-title":"Int J Obes"},{"key":"BF1001869_CR35","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/BF02598217","volume":"6","author":"AS Petrulis","year":"1991","unstructured":"Petrulis AS, Imperiale TF, Speroff T . The acute effect of phenylpropanolamine and brompheniramine on blood pressure in controlled hypertension: a randomized double-blind crossover trial. J Gen Intern Med 1991; 6: 503\u2013506.","journal-title":"J Gen Intern Med"},{"key":"BF1001869_CR36","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1177\/030006057900700312","volume":"7","author":"U Renvall","year":"1979","unstructured":"Renvall U, Lindqvist N . A double-blind clinical study with Monydrin tablets in patients with non-allergic chronic rhinitis. J Int Med Res 1979; 7: 235\u2013239.","journal-title":"J Int Med Res"},{"key":"BF1001869_CR37","first-page":"15","volume":"70","author":"JM Rosene","year":"1999","unstructured":"Rosene JM, Rosene JA, Koczajowski DL, Paolone VJ . Decongestant effects on hemodynamics at rest, exercise, and recovery from exercise during \u2014 6 degrees of head down tilt. Aviat Space Environ Med 1999; 70: 15\u201321.","journal-title":"Aviat Space Environ Med"},{"key":"BF1001869_CR38","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1002\/j.1550-8528.1997.tb00673.x","volume":"5","author":"PA Rushing","year":"1997","unstructured":"Rushing PA, Winders SE, Watson SL, Klesges RC . Acute administration of phenylpropanolamine fails to affect resting energy expenditure in men of normal weight. Obes Res 1997; 5: 470\u2013473.","journal-title":"Obes Res"},{"key":"BF1001869_CR39","first-page":"746","volume":"17","author":"MB Saltzman","year":"1983","unstructured":"Saltzman MB, Dolan MM, Doyne N . Comparison of effects of two dosage regimens of phenylpropanolamine on blood pressure and plasma levels in normal subjects under steady-state conditions. Drug Intell Clin Pharm 1983; 17: 746\u2013750.","journal-title":"Drug Intell Clin Pharm"},{"key":"BF1001869_CR40","first-page":"168","volume":"11","author":"CD Sands","year":"1992","unstructured":"Sands CD, Jung KM, Jones DW, Kim HJ . Effect of phenylpropanolamine hydrochloride on blood pressure in Korean patients with hypertension controlled by hydrochlorothiazide. Clin Pharm 1992; 11: 168\u2013173.","journal-title":"Clin Pharm"},{"key":"BF1001869_CR41","first-page":"487","volume":"16","author":"DE Schteingart","year":"1992","unstructured":"Schteingart DE . Effectiveness of phenylpropanolamine in the management of moderate obesity. Int J Obes Relat Metab Disord 1992; 16: 487\u2013493.","journal-title":"Int J Obes Relat Metab Disord"},{"key":"BF1001869_CR42","first-page":"185","volume":"28","author":"HI Silverman","year":"1980","unstructured":"Silverman HI, Kreger BE, Lewis GP . Lack of side effects from orally administered phenylpropanolamine and phenylplropanolamine with caffeine: a controlled three-phase study. Curr Therap Res Clin Expe 1980; 28: 185\u2013194.","journal-title":"Curr Therap Res Clin Expe"},{"key":"BF1001869_CR43","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1097\/00042752-199707000-00003","volume":"7","author":"RA Swain","year":"1997","unstructured":"Swain RA, Harsha DM, Baenziger J, Saywell Jr RM . Do pseudoephedrine or phenylpropanolamine improve maximum oxygen uptake and time to exhaustion? Clin J Sport Med 1997; 7: 168\u2013173.","journal-title":"Clin J Sport Med"},{"key":"BF1001869_CR44","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/clpt.1986.87","volume":"39","author":"M Weintraub","year":"1986","unstructured":"Weintraub M et al. Phenylpropanolamine OROS (Acutrim) vs placebo in combination with caloric restriction and physician-managed behavior modification. Clin Pharmacol Ther 1986; 39: 501\u2013509.","journal-title":"Clin Pharmacol Ther"},{"key":"BF1001869_CR45","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1023\/A:1015852012968","volume":"7","author":"CL Zimmerman","year":"1990","unstructured":"Zimmerman CL, O'Connell MB, Soria I . The effects of urine pH modification on the pharmacokinetics and pharmacodynamics of phenylpropanolamine. Pharm Res 1990; 7: 96\u2013102.","journal-title":"Pharm Res"},{"key":"BF1001869_CR46","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/j.1398-9995.1982.tb01879.x","volume":"37","author":"P Broms","year":"1982","unstructured":"Broms P, Malm L . Oral vasoconstrictors in perennial non-allergic rhinitis. Allergy 1982; 37: 67\u201374.","journal-title":"Allergy"},{"key":"BF1001869_CR47","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1001\/jama.1987.03400020078035","volume":"258","author":"I Biaggioni","year":"1987","unstructured":"Biaggioni I, Onrot J, Stewart CK, Robertson D . The potent pressor effect of phenylpropanolamine in patients with autonomic impairment. JAMA 1987; 258: 236\u2013239.","journal-title":"JAMA"},{"key":"BF1001869_CR48","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/clpt.1989.25","volume":"45","author":"MB O\u2019Connell","year":"1989","unstructured":"O\u2019Connell MB, Pentel PR, Zimmerman CL . Individual variability in the blood pressure response to intravenous phenylpropanolamine: a pharmacokinetic and pharmacodynamic investigation. Clin Pharmacol Ther 1989; 45: 252\u2013259.","journal-title":"Clin Pharmacol Ther"}],"container-title":["Journal of Human Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1001869.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1001869","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1001869.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,26]],"date-time":"2024-01-26T13:21:14Z","timestamp":1706275274000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1001869"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4,21]]},"references-count":48,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2005,8,1]]}},"alternative-id":["BF1001869"],"URL":"https:\/\/doi.org\/10.1038\/sj.jhh.1001869","relation":{},"ISSN":["0950-9240","1476-5527"],"issn-type":[{"value":"0950-9240","type":"print"},{"value":"1476-5527","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,4,21]]},"assertion":[{"value":"3 January 2005","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2005","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2005","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}